vs
Side-by-side financial comparison of InfuSystem Holdings, Inc (INFU) and SOUTH PLAINS FINANCIAL, INC. (SPFI). Click either name above to swap in a different company.
SOUTH PLAINS FINANCIAL, INC. is the larger business by last-quarter revenue ($54.1M vs $36.2M, roughly 1.5× InfuSystem Holdings, Inc). Over the past eight quarters, InfuSystem Holdings, Inc's revenue compounded faster (6.4% CAGR vs 5.6%).
InfuSystem Holdings, Inc. is a U.S.-headquartered healthcare provider specializing in infusion therapy solutions. It supplies programmable infusion pumps, matching disposable medical consumables, and professional clinical support services, serving oncology clinics, home healthcare providers, and acute care facilities across North America.
Ally Financial Inc. is an American bank holding company incorporated in Delaware and headquartered at Ally Detroit Center in Detroit, Michigan. The company provides financial services including car finance, online banking via a direct bank, corporate lending, vehicle insurance, mortgage loans, and other related financing services such as installment sale and lease agreements.
INFU vs SPFI — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $36.2M | $54.1M |
| Net Profit | — | $14.5M |
| Gross Margin | 56.4% | — |
| Operating Margin | 10.3% | — |
| Net Margin | — | 26.9% |
| Revenue YoY | 7.0% | — |
| Net Profit YoY | — | 18.3% |
| EPS (diluted) | $0.09 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $54.1M | ||
| Q4 25 | $36.2M | $53.9M | ||
| Q3 25 | $36.5M | $54.2M | ||
| Q2 25 | $36.0M | $54.7M | ||
| Q1 25 | $34.7M | $49.2M | ||
| Q4 24 | $33.8M | $51.9M | ||
| Q3 24 | $35.3M | $47.9M | ||
| Q2 24 | $33.7M | $48.6M |
| Q1 26 | — | $14.5M | ||
| Q4 25 | — | — | ||
| Q3 25 | $2.3M | $16.3M | ||
| Q2 25 | $2.6M | $14.6M | ||
| Q1 25 | $-267.0K | $12.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | $1.8M | $11.2M | ||
| Q2 24 | $717.0K | $11.1M |
| Q1 26 | — | — | ||
| Q4 25 | 56.4% | — | ||
| Q3 25 | 57.1% | — | ||
| Q2 25 | 55.2% | — | ||
| Q1 25 | 55.2% | — | ||
| Q4 24 | 53.8% | — | ||
| Q3 24 | 53.9% | — | ||
| Q2 24 | 49.5% | — |
| Q1 26 | — | — | ||
| Q4 25 | 10.3% | 35.4% | ||
| Q3 25 | 10.4% | 38.1% | ||
| Q2 25 | 10.5% | 34.1% | ||
| Q1 25 | 1.8% | 31.9% | ||
| Q4 24 | 7.7% | 39.9% | ||
| Q3 24 | 9.2% | 29.8% | ||
| Q2 24 | 5.5% | 29.3% |
| Q1 26 | — | 26.9% | ||
| Q4 25 | — | — | ||
| Q3 25 | 6.2% | 30.1% | ||
| Q2 25 | 7.2% | 26.7% | ||
| Q1 25 | -0.8% | 25.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | 5.1% | 23.4% | ||
| Q2 24 | 2.1% | 22.9% |
| Q1 26 | — | — | ||
| Q4 25 | $0.09 | $0.90 | ||
| Q3 25 | $0.11 | $0.96 | ||
| Q2 25 | $0.12 | $0.86 | ||
| Q1 25 | $-0.01 | $0.72 | ||
| Q4 24 | $0.05 | $0.96 | ||
| Q3 24 | $0.08 | $0.66 | ||
| Q2 24 | $0.03 | $0.66 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.2M | $722.0M |
| Total DebtLower is stronger | $19.6M | $3.0K |
| Stockholders' EquityBook value | $57.3M | $504.9M |
| Total Assets | $100.6M | $4.6B |
| Debt / EquityLower = less leverage | 0.34× | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $722.0M | ||
| Q4 25 | $3.2M | $552.4M | ||
| Q3 25 | $955.0K | $635.0M | ||
| Q2 25 | $720.0K | $470.5M | ||
| Q1 25 | $1.5M | $536.3M | ||
| Q4 24 | $527.0K | $359.1M | ||
| Q3 24 | $380.0K | $471.2M | ||
| Q2 24 | $146.0K | $298.0M |
| Q1 26 | — | $3.0K | ||
| Q4 25 | $19.6M | — | ||
| Q3 25 | $20.9M | — | ||
| Q2 25 | $26.3M | — | ||
| Q1 25 | $28.7M | — | ||
| Q4 24 | $23.9M | — | ||
| Q3 24 | $28.0M | — | ||
| Q2 24 | $34.2M | — |
| Q1 26 | — | $504.9M | ||
| Q4 25 | $57.3M | $493.8M | ||
| Q3 25 | $55.5M | $477.8M | ||
| Q2 25 | $54.5M | $454.1M | ||
| Q1 25 | $55.1M | $443.7M | ||
| Q4 24 | $57.5M | $438.9M | ||
| Q3 24 | $55.5M | $443.1M | ||
| Q2 24 | $53.5M | $418.0M |
| Q1 26 | — | $4.6B | ||
| Q4 25 | $100.6M | $4.5B | ||
| Q3 25 | $98.9M | $4.5B | ||
| Q2 25 | $100.8M | $4.4B | ||
| Q1 25 | $104.3M | $4.4B | ||
| Q4 24 | $103.6M | $4.2B | ||
| Q3 24 | $105.3M | $4.3B | ||
| Q2 24 | $108.5M | $4.2B |
| Q1 26 | — | 0.00× | ||
| Q4 25 | 0.34× | — | ||
| Q3 25 | 0.38× | — | ||
| Q2 25 | 0.48× | — | ||
| Q1 25 | 0.52× | — | ||
| Q4 24 | 0.41× | — | ||
| Q3 24 | 0.50× | — | ||
| Q2 24 | 0.64× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $7.1M | — |
| Free Cash FlowOCF − Capex | $7.0M | — |
| FCF MarginFCF / Revenue | 19.3% | — |
| Capex IntensityCapex / Revenue | 0.4% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $23.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $7.1M | $77.5M | ||
| Q3 25 | $8.5M | $24.2M | ||
| Q2 25 | $7.0M | $14.7M | ||
| Q1 25 | $1.8M | $26.1M | ||
| Q4 24 | $7.9M | $59.4M | ||
| Q3 24 | $9.8M | $17.9M | ||
| Q2 24 | $2.3M | $18.2M |
| Q1 26 | — | — | ||
| Q4 25 | $7.0M | $71.8M | ||
| Q3 25 | $8.4M | $22.5M | ||
| Q2 25 | $6.8M | $13.0M | ||
| Q1 25 | $1.6M | $25.0M | ||
| Q4 24 | $7.4M | $56.0M | ||
| Q3 24 | $9.8M | $17.1M | ||
| Q2 24 | $2.0M | $17.1M |
| Q1 26 | — | — | ||
| Q4 25 | 19.3% | 133.3% | ||
| Q3 25 | 23.1% | 41.5% | ||
| Q2 25 | 18.9% | 23.8% | ||
| Q1 25 | 4.7% | 50.8% | ||
| Q4 24 | 21.9% | 108.0% | ||
| Q3 24 | 27.7% | 35.7% | ||
| Q2 24 | 5.9% | 35.2% |
| Q1 26 | — | — | ||
| Q4 25 | 0.4% | 10.5% | ||
| Q3 25 | 0.2% | 3.2% | ||
| Q2 25 | 0.6% | 3.2% | ||
| Q1 25 | 0.4% | 2.3% | ||
| Q4 24 | 1.6% | 6.5% | ||
| Q3 24 | 0.1% | 1.6% | ||
| Q2 24 | 1.0% | 2.2% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 3.76× | 1.48× | ||
| Q2 25 | 2.70× | 1.01× | ||
| Q1 25 | — | 2.12× | ||
| Q4 24 | — | — | ||
| Q3 24 | 5.45× | 1.59× | ||
| Q2 24 | 3.22× | 1.63× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
INFU
| Patient Services | $20.0M | 55% |
| Device Solutions | $14.4M | 40% |
| Other | $1.9M | 5% |
SPFI
| Net Interest Income | $42.9M | 79% |
| Noninterest Income | $11.3M | 21% |
